These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18616864)

  • 21. Looking inside the nation's medicine cabinet: trends in outpatient drug spending by Medicare beneficiaries, 1997 and 2001.
    Moeller JF; Miller GE; Banthin JS
    Health Aff (Millwood); 2004; 23(5):217-25. PubMed ID: 15371388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Medicare Part D doughnut hole: effect on pharmacy utilization.
    Sun SX; Lee KY
    Manag Care Interface; 2007 Sep; 20(9):51-5, 59. PubMed ID: 18161394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the Medicare Part D prescription program: partnerships for beneficiaries and health care professionals.
    De Natale ML
    Policy Polit Nurs Pract; 2007 Aug; 8(3):170-81. PubMed ID: 18178923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of Medicare Part D beneficiaries who reach the drug benefit threshold in both of the first two years of the Part D benefit.
    Bayliss EA; Ellis JL; Delate T; Steiner JF; Raebel MA
    Med Care; 2010 Mar; 48(3):267-72. PubMed ID: 20125044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with psychotropic prescriptions, psychiatric hospitalization, and spending among Medicare beneficiaries under 65.
    Qian J; Wittayanukorn S; McGuffey G; Hansen R
    Disabil Health J; 2015 Jul; 8(3):424-33. PubMed ID: 25890881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
    Polinski JM; Mohr PE; Johnson L
    Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the impact of coverage gaps in the Medicare Part D drug benefit.
    Stuart B; Simoni-Wastila L; Chauncey D
    Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-167-W5-179. PubMed ID: 15840626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of obesity on rising medical spending.
    Thorpe KE; Florence CS; Howard DH; Joski P
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-480-6. PubMed ID: 15496437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How disease burden influences medication patterns for Medicare beneficiaries: implications for policy.
    Stuart BC
    Issue Brief (Commonw Fund); 2008 Feb; 30():1-12. PubMed ID: 18360960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Savings from drug discount cards: relief for Medicare beneficiaries?
    Cubanski J; Frank RG; Epstein AM
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-198-209. PubMed ID: 15451980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of drug consumption patterns for Medicare Part D patients.
    Pedan A; Lu J; Varasteh LT
    Am J Manag Care; 2009 May; 15(5):323-7. PubMed ID: 19435400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity utilization and health-related quality of life in Medicare enrollees.
    Malinoff RL; Elliott MN; Giordano LA; Grace SC; Burroughs JN
    J Ambul Care Manage; 2013; 36(1):61-71. PubMed ID: 23222013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The rise in spending among Medicare beneficiaries: the role of chronic disease prevalence and changes in treatment intensity.
    Thorpe KE; Howard DH
    Health Aff (Millwood); 2006; 25(5):w378-88. PubMed ID: 16926180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clarifying sources of geographic differences in Medicare spending.
    Zuckerman S; Waidmann T; Berenson R; Hadley J
    N Engl J Med; 2010 Jul; 363(1):54-62. PubMed ID: 20463333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing patterns in medication use with increasing probability of death for older Medicare beneficiaries.
    Shaffer T; Simoni-Wastila L; Toler W; Stuart B; Doshi JA
    J Am Geriatr Soc; 2010 Aug; 58(8):1549-55. PubMed ID: 20670381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential impact of Medicare Part D in the end-stage renal disease population.
    St Peter WL
    Adv Chronic Kidney Dis; 2008 Apr; 15(2):140-6. PubMed ID: 18334238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regions with higher Medicare Part D spending show better drug adherence, but not lower medicare costs for two diseases.
    Stuart B; Shoemaker JS; Dai M; Davidoff AJ
    Health Aff (Millwood); 2013 Jan; 32(1):120-6. PubMed ID: 23297279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries.
    Gruber-Baldini AL; Stuart B; Zuckerman IH; Simoni-Wastila L; Miller R
    J Am Geriatr Soc; 2007 Oct; 55(10):1508-16. PubMed ID: 17727648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting demand among older adults for medication therapy management services.
    Brooks JM; Unni EJ; Klepser DG; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2008 Dec; 4(4):309-19. PubMed ID: 19064238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.